3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
12
Phase 1/2
12
Phase 3
9
Phase 1
8
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Skin Neoplasms
3
Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Melanoma
2
Carcinoma, Hepatocellular
2
Turcot syndrome
1
Recurrence
1
Prostatic Neoplasms
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Neoplasm Metastasis
1
Neoadjuvant Therapy
1
Mouth Neoplasms
1
Malignant Ascites
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Small Cell
1
Carcinoma, Endometrioid
1
Carcinoma
1
Interventions
Radiotherapy
2
Practice Guidelines as Topic
2
Heavy Ion Radiotherapy
2
seocalcitol
1
pembrolizumab
1
Yoga
1
X-Rays
1
Tomography, Optical Coherence
1
Surveys and Questionnaires
1
Standard of Care
1
Sentinel Lymph Node Biopsy
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiofrequency Ablation
1
Pluvicto
1
Platinum Compounds
1
Pemetrexed
1
Nurses
1
Nivolumab
1
Nimorazole
1
NF protocol
1
Magnetic Resonance Spectroscopy
1
Lasers, Solid-State
1
Lasers, Gas
1
Itraconazole
1
Inulin
1
Interviews as Topic
1
Hearing
1
Fluorodeoxyglucose F18
1
Exercise
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Carcinoma
×
pembrolizumab
×
Clear all
NCT05821751
2023-04-20
PRINCESS
Fondazione del Piemonte per l'Oncologia
Phase NA
Unknown
40 enrolled